VK2735 for Weight Management Phase 3 is a research study to test a new medicine, VK2735, for helping people lose weight. This study will last for 78 weeks, which is about a year and a half. It's called a "phase 3" study, meaning it's a later stage of testing. Participants won’t know if they're getting the actual medicine or a "placebo," which is a harmless pill that doesn't have any medicine. This helps scientists see if the medicine really works. The study focuses on people who are obese (very overweight) or overweight with health issues like high blood pressure or heart problems, but not diabetes.
- Length: 78 weeks, which is about 1.5 years.
- Participants: Adults 18+ who are overweight or obese without diabetes.
- Risks: Cannot join if you have certain health issues or recent weight changes.
If you're thinking about joining, remember it's a long commitment. You will help doctors learn if VK2735 is safe and effective for weight loss.
How understandable was the trial content above?
Hard to understand
Easy to understand